In this work, we have developed DOX‐loaded nanoMIPs for their targeted delivery to ERα positive BC cell lines to improve breast cancer treatment via double imprinting with an epitope of ERα in the presence of DOX. The gene discussed is ESR1; the disease is breast carcinoma.